Dr. Francis P. Worden
Claim this profileUniversity of Michigan
Studies Squamous Cell Carcinoma
Studies Thyroid Cancer
13 reported clinical trials
23 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage III
HPV16 positive
2Thyroid Cancer
RET positive
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Francis P. Worden is currently running
ADT + Pembrolizumab
for Salivary Gland Cancer
A Phase II, multi-center, single-arm, non-blinded study combining androgen deprivation therapy (ADT) and pembrolizumab for patients with metastatic or locally recurrent androgen receptor-positive salivary gland carcinoma, not amenable to surgery or radiation.
Recruiting1 award Phase 221 criteria
Cyclophosphamide + Sirolimus
for Advanced Thyroid Cancer
This trial uses two drugs, Cyclophosphamide and Sirolimus, to treat patients with thyroid cancer that has spread. Cyclophosphamide kills cancer cells by breaking their DNA, while Sirolimus stops them from growing. Sirolimus has been used in various treatments and has shown effectiveness against different cancers. Patients are monitored for side effects and effectiveness.
Recruiting1 award Phase 211 criteria
More about Francis P. Worden
Clinical Trial Related6 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Francis P. Worden has experience with
- Pembrolizumab
- Cisplatin
- Selpercatinib
- Intensity-Modulated Radiation Therapy
- Cyclophosphamide
- Sirolimus
Breakdown of trials Francis P. Worden has run
Squamous Cell Carcinoma
Thyroid Cancer
Medullary Thyroid Cancer
Medullary Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Francis P. Worden specialize in?
Francis P. Worden focuses on Squamous Cell Carcinoma and Thyroid Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Francis P. Worden currently recruiting for clinical trials?
Yes, Francis P. Worden is currently recruiting for 6 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Francis P. Worden has studied deeply?
Yes, Francis P. Worden has studied treatments such as Pembrolizumab, Cisplatin, Selpercatinib.
What is the best way to schedule an appointment with Francis P. Worden?
Apply for one of the trials that Francis P. Worden is conducting.
What is the office address of Francis P. Worden?
The office of Francis P. Worden is located at: University of Michigan, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.